Novotech receives CRO Leadership Awards recognition from Life Science Leader

Life Science Leader Magazine featured Novotech in its May edition’s CRO supplement and attributed individual awards in several categories including data quality, responsiveness and meeting overall project timelines.

기타 관련 콘텐츠

11월 27, 2023 News

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Read more

11월 22, 2023 News

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Read more

11월 14, 2023 News

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Read more

11월 14, 2023 News

Navigating the Complexities of Planning and Executing Multiregional Clinical Trials

Read more

11월 8, 2023 News

Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials…

Read more

11월 6, 2023 News

Driving Progress Towards Gender Equality and Inclusion

Read more

11월 7, 2023 News

Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

Read more

11월 6, 2023 News

Novotech, 주요 경영진 임명: 북미 총괄 Rick Farris, 바이오메트릭스 & 데이터 부문 글로벌 총괄이자 부사장 Dr. David Ng

Read more

10월 11, 2023 News

Novotech, Frost&Sullivan ‘올해의 CRO 기업’ 연속 선정

Read more

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)

이상지질혈증– 글로벌 임상 시험 환경 (2023)

Clinical trials in China: unlocking the potential of advanced therapies

BIO 2023에서 Endpoint 웨비나: 바이오테크 분야에서 중국과의 관계 구축

전 세계 보건을 위한 백신 R&D 가속화에 전념하는 다국적 기업의 글로벌 코로나 19 백신 연구를 위한 시험대상자의 신속한 등록 성공 사례

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Covid-19 공지 중요 업데이트

다음과 관련된 콘텐츠 찾기:

AES 2023 Annual Meeting

OCT East Asia 2023

의료 및 규제

환자 모집

CNS 솔루션 > 초기 단계 CRO 서비스

임상 운영

Site Management Organization (SMO)

바이오메트릭스 및 데이터 관리

가상 임상시험

실사용 데이터

생물분석 실험실 서비스

종양학 CRO 서비스

계량약리학 서비스

의약품 개발 계획

CNS의 고유 GMO 솔루션

간질환 CRO 서비스

감염성 질환 및 백신 CRO 서비스

희귀질환 CRO 서비스

임상 및 규제 전략

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

우리의 사명：모든 사람에게 성장의 기회를 창조한다.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Novotech receives CRO Leadership Awards recognition from Life Science Leader

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)

이상지질혈증– 글로벌 임상 시험 환경 (2023)

Clinical trials in China: unlocking the potential of advanced therapies

BIO 2023에서 Endpoint 웨비나: 바이오테크 분야에서 중국과의 관계 구축

전 세계 보건을 위한 백신 R&D 가속화에 전념하는 다국적 기업의 글로벌 코로나 19 백신 연구를 위한 시험대상자의 신속한 등록 성공 사례

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Covid-19 공지 중요 업데이트

다음과 관련된 콘텐츠 찾기:

AES 2023 Annual Meeting

OCT East Asia 2023

의료 및 규제

환자 모집

CNS 솔루션 > 초기 단계 CRO 서비스

임상 운영

Site Management Organization (SMO)

바이오메트릭스 및 데이터 관리

가상 임상시험

실사용 데이터

생물분석 실험실 서비스

종양학 CRO 서비스

계량약리학 서비스

의약품 개발 계획

CNS의 고유 GMO 솔루션

간질환 CRO 서비스

감염성 질환 및 백신 CRO 서비스

희귀질환 CRO 서비스

임상 및 규제 전략

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

우리의 사명：모든 사람에게 성장의 기회를 창조한다.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

기타 관련 콘텐츠

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Navigating the Complexities of Planning and Executing Multiregional Clinical Trials

Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials…

Driving Progress Towards Gender Equality and Inclusion

Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

Novotech, 혈우병 및 원발성 담즙성 담관염(PBC)에 대한 2023 글로벌 임상시험 환경 심층 보고서 발간

Novotech, 임상 서비스 글로벌 총괄이자 부사장 김윤이 박사, Veeva Korea Summit에서 기조연설

노보텍(Novotech), Judith Ng-Cashin 박사를 최고의료책임자(Chief Medical Officer)로 임명

Novotech, 주요 경영진 임명: 북미 총괄 Rick Farris, 바이오메트릭스 & 데이터 부문 글로벌 총괄이자 부사장 Dr. David Ng

Novotech, Frost&Sullivan ‘올해의 CRO 기업’ 연속 선정